Importance of antifungal drug-resistance: Clinical significance and need for novel therapy

Expert Opinion on Investigational Drugs

Volumn 7, Issue 2, 1998, Pages 175-198

  Frosco, M B ^a   Barrett, J F ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

Antifungal; Aspergillus; Azoles; Candida; Cryptococcus; Echinocandins; Histoplasma; Polyenes; Resistance

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; GRISEOFULVIN; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; POLYENE; PYRROLE DERIVATIVE; TERBINAFINE; TRIAZOLE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIFUNGAL ACTIVITY; ASPERGILLUS; CANDIDA; CANDIDIASIS; CRYPTOCOCCUS; HISTOPLASMA; HISTOPLASMOSIS; HOSPITAL INFECTION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; PROPHYLAXIS; REVIEW;

EID: 0031985762     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.7.2.175     Document Type: Review

References (221)